BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 28187280)

  • 1. Cancer Clinical Trials: The Rear-View Mirror and the Crystal Ball.
    Cescon D; Siu LL
    Cell; 2017 Feb; 168(4):575-578. PubMed ID: 28187280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The evolving war on cancer.
    Haber DA; Gray NS; Baselga J
    Cell; 2011 Apr; 145(1):19-24. PubMed ID: 21458664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical cancer advances 2011: Annual Report on Progress Against Cancer from the American Society of Clinical Oncology.
    Vogelzang NJ; Benowitz SI; Adams S; Aghajanian C; Chang SM; Dreyer ZE; Janne PA; Ko AH; Masters GA; Odenike O; Patel JD; Roth BJ; Samlowski WE; Seidman AD; Tap WD; Temel JS; Von Roenn JH; Kris MG
    J Clin Oncol; 2012 Jan; 30(1):88-109. PubMed ID: 22147736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 'Basket studies' will hold intricate data for cancer drug approvals.
    Willyard C
    Nat Med; 2013 Jun; 19(6):655. PubMed ID: 23744135
    [No Abstract]   [Full Text] [Related]  

  • 5. Trend toward noninferiority trials may mean more difficult interpretation of trial results.
    Tuma RS
    J Natl Cancer Inst; 2007 Dec; 99(23):1746-8. PubMed ID: 18042926
    [No Abstract]   [Full Text] [Related]  

  • 6. New Clinical Trial Designs Hasten Approvals for Targeted Therapies.
    Schmidt C
    J Natl Cancer Inst; 2016 Mar; 108(3):. PubMed ID: 26944760
    [No Abstract]   [Full Text] [Related]  

  • 7. The seamless approach to drug development in oncology.
    Pazdur R
    Clin Adv Hematol Oncol; 2016 Dec; 14(12):958-959. PubMed ID: 28212356
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical trials and drug approvals continue to accelerate in China.
    Wang M
    Lancet Oncol; 2017 Jul; 18(7):855. PubMed ID: 28552212
    [No Abstract]   [Full Text] [Related]  

  • 9. Mea Culpa with cancer-targeted therapy: new thinking and new agents design for novel, causal networks-based, personalized biomedicine.
    Roukos DH
    Expert Rev Mol Diagn; 2009 Apr; 9(3):217-21. PubMed ID: 19379079
    [No Abstract]   [Full Text] [Related]  

  • 10. Cancer research. As questions grow, Duke halts trials, launches investigation.
    Couzin-Frankel J
    Science; 2010 Aug; 329(5992):614-5. PubMed ID: 20688986
    [No Abstract]   [Full Text] [Related]  

  • 11. Epidermal growth factor receptor inhibitors: current status and future directions.
    Chen HX; Cleck JN; Coelho R; Dancey JE
    Curr Probl Cancer; 2009; 33(4):245-94. PubMed ID: 20082842
    [No Abstract]   [Full Text] [Related]  

  • 12. Rare cancer trial design: lessons from FDA approvals.
    Gaddipati H; Liu K; Pariser A; Pazdur R
    Clin Cancer Res; 2012 Oct; 18(19):5172-8. PubMed ID: 22718862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current status of oral anticancer drugs in Japan.
    Fujiwara Y
    J Clin Oncol; 1999 Oct; 17(10):3362-5. PubMed ID: 10506642
    [No Abstract]   [Full Text] [Related]  

  • 14. Progression-free survival as an end-point in solid tumours--perspectives from clinical trials and clinical practice.
    Robinson AG; Booth CM; Eisenhauer EA
    Eur J Cancer; 2014 Sep; 50(13):2303-8. PubMed ID: 24974171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preface. Combining clinical, translational and basic cancer drug research: the 2008 CESAR annual meeting.
    Brockmoeller J; Sehrt D; Scheulen ME
    Int J Clin Pharmacol Ther; 2009 Jan; 47(1):30-2. PubMed ID: 19203530
    [No Abstract]   [Full Text] [Related]  

  • 16. Veterinary oncology clinical trials: design and implementation.
    Thamm DH; Vail DM
    Vet J; 2015 Aug; 205(2):226-32. PubMed ID: 25582798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An audience with Tatiana Prowell. Interviewed by Asher Mullard.
    Prowell T
    Nat Rev Drug Discov; 2014 Jun; 13(6):410-1. PubMed ID: 24875091
    [No Abstract]   [Full Text] [Related]  

  • 18. Next-Generation Sequencing to Guide Clinical Trials.
    Siu LL; Conley BA; Boerner S; LoRusso PM
    Clin Cancer Res; 2015 Oct; 21(20):4536-44. PubMed ID: 26473189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug Development, Trial Design, and Endpoints in Oncology: Adapting to Rapidly Changing Science.
    Blumenthal GM; Goldberg KB; Pazdur R
    Clin Pharmacol Ther; 2017 May; 101(5):572-574. PubMed ID: 28074476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The conduct of therapeutic trials in cancer medicine.
    Rudnick S; Capizzi RL
    Semin Oncol; 1977 Jun; 4(2):255-8. PubMed ID: 327556
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.